FDAnews Announces The Drug Industry Daily Newsletter Publication



Get intelligence on key industry issues worldwide to increase one’s competitive edge. Drug Industry Daily is the key to success.

Drug Industry Daily
FDAnews Publication

Want pharma success? It begins with staying ahead of industry developments and harnessing intelligence that pertains to your business. It requires Drug Industry Daily.

Now, the daily go-to source of information for the global pharma industry is even more vital. Merged with The Drug GMP Report and the free daily briefing, Drug Daily Bulletin, the upgraded Drug Industry Daily is all the news one has come to rely on with analysis of developing trends and deeper dives into specific areas of concern for drugmakers.

Stay up-to-date on regulatory and legislative developments, along with actions taken by the current administration, FDA and other federal agencies that impact drug manufacturers, including handling FDA inspections, validating equipment and processes, risk-based quality management, handling suppliers and vendors, and protecting the drug supply chain.

It’s quality one can rely on, as Drug Industry Daily is reported and written by FDAnews’ team of experienced drug industry journalists and subject matter experts. Combined with all of the articles included in the Drug Daily Bulletin and timely content from FDAnews management reports and webinars, don’t go without valuable insights into:

  • Breaking news on COVID-19 (including the launch of new trials; the approvals of vaccines and treatments; and supply deals that the U.S., EC and other governments have struck with drugmakers)
  • Regulatory developments and new regulatory policies by the FDA and other regulatory agency guidances
  • Pharma company mergers, especially when a company is getting into a new therapeutic area
  • Analyses of developments in the pharma industry
  • Developments in drug pricing and drug labeling policies
  • FDA budgets and spending, including approvals and proposals by Congress and the president
  • FDA management and structure
  • Quality and GMP regulatory policies and developments in the industry
  • Patent exclusivity lawsuit rulings and developments
  • FDA inspection policies and schedules
  • FDA enforcement actions
  • Global enforcement trends
  • Pharmacovigilance developments in the EU and elsewhere
  • Recalls

Get ahead — and stay compliant — with the major breaking pharma developments and analysis in the new Drug Industry Daily.

Publication Details:
Drug Industry Daily
FDAnews Publication


Easy Ways to Order:
Online: https://www.fdanews.com/subscribe-now/drug-industry-daily
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email: